Revista Colombiana de Psiquiatría
versão impressa ISSN 0034-7450
Introduction: Recent large independent studies show no clear difference between the thoughtful use of older generation drugs and the new atypicals for people with schizophrenia. Objective: Along with well-conducted systematic reviews of all available evidence, these studies assist clinicians to make informed treatment choices. Results and conclusions: These choices should be less directed by guilt generated by the pecuniary interest of industry, and more based on the judicious use of the best evidence.
Palavras-chave : Schizophrenia; physicians role; antipsychotic agents.